Results from this study were previously presented at the North American Spine Society Meeting in 2011 and 2012, International Society for Advancement of Spine Surgery Meeting in 2010, Cervical Spine Research Society Meeting in 2011 and 2012, Eurospine in 2011, and AANS/CNS Joint Spine Section Meeting in 2011.
Bui TLSpector LOdum SDarden BVSegabarth BPatti J: Adjacent segment degeneration following ProDisc-C Total Disc Replacement (TDR) and Anterior Cervical Discectomy and Fusion (ACDF): does surgeon bias effect radiographic interpretation?. Presented at the annual meeting of the Cervical Spine Research SocietyChicago2012(Abstract) (http://www.csrs.org/web/searchAbstr/2012_Paper33.pdf) [Accessed July 8 2013]
Carreon LYGlassman SDCampbell MJAnderson PA: Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion. Spine J 10:469–4742010
Coric DNunley PDGuyer RDMusante DCarmody CNGordon CR: Prospective, randomized, multicenter study of cervical arthroplasty: 269 patients from the Kineflex|C artificial disc investigational device exemption study with a minimum 2-year follow-up. Clinical article. J Neurosurg Spine 15:348–3582011
Davis RJBae HWGaede SEHisey MSKim KDNunley PD: Radiographic outcomes including adjacent level degeneration of FDA investigational device trial comparing multi-level use of Mobi-C Cervical Artificial Disc to anterior discectomy and fusion. Presented at the annual meeting of the Cervical Spine Research SocietyScottsdale, AZ2011(Abstract) (http://www.csrs.org/web/searchAbstr/2011_Paper68.pdf) [Accessed July 8 2013]
Heller JGSasso RCPapadopoulos SMAnderson PAFessler RGHacker RJ: Comparison of BRYAN cervical disc arthroplasty with anterior cervical decompression and fusion: clinical and radiographic results of a randomized, controlled, clinical trial. Spine (Phila Pa 1976) 34:101–1072009
Murrey DJanssen MDelamarter RGoldstein JZigler JTay B: Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Spine J 9:275–2862009
Ohnmeiss DHisey MSBae HDavis RJHoffman GAKim K: Multicenter, prospective, randomized, controlled investigational device exemption study comparing Mobi C Cervical Artificial Disc to anterior fusion in the treatment of symptomatic cervical degenerative disc disease. Spine J 11 SupplS16–S172011. (Abstract)